First Time Loading...

Insmed Inc
NASDAQ:INSM

Watchlist Manager
Insmed Inc Logo
Insmed Inc
NASDAQ:INSM
Watchlist
Price: 25.535 USD -0.06%
Updated: May 6, 2024

Insmed Inc
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Insmed Inc
Revenue Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Revenue Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Insmed Inc
NASDAQ:INSM
Revenue
$305.2m
CAGR 3-Years
23%
CAGR 5-Years
99%
CAGR 10-Years
39%
Abbvie Inc
NYSE:ABBV
Revenue
$54.3B
CAGR 3-Years
6%
CAGR 5-Years
11%
CAGR 10-Years
11%
Gilead Sciences Inc
NASDAQ:GILD
Revenue
$27.5B
CAGR 3-Years
2%
CAGR 5-Years
4%
CAGR 10-Years
7%
Amgen Inc
NASDAQ:AMGN
Revenue
$28.2B
CAGR 3-Years
4%
CAGR 5-Years
3%
CAGR 10-Years
4%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Revenue
$9.9B
CAGR 3-Years
17%
CAGR 5-Years
26%
CAGR 10-Years
23%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Revenue
$13.1B
CAGR 3-Years
16%
CAGR 5-Years
14%
CAGR 10-Years
20%

Insmed Inc
Revenue Breakdown

Breakdown by Geography
Insmed Inc

Total Revenue: 305.2m USD
100%
Us: 224.2m USD
73.5%
Japan: 65.7m USD
21.5%
Europe And Rest Of World: 15.3m USD
5%

Breakdown by Segments
Insmed Inc

Not Available

See Also

What is Insmed Inc's Revenue?
Revenue
305.2m USD

Based on the financial report for Dec 31, 2023, Insmed Inc's Revenue amounts to 305.2m USD.

What is Insmed Inc's Revenue growth rate?
Revenue CAGR 10Y
39%

Over the last year, the Revenue growth was 24%. The average annual Revenue growth rates for Insmed Inc have been 23% over the past three years , 99% over the past five years , and 39% over the past ten years .